Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular
Free webinar: Telepathology: is there added value in LMICs?
Free webinar: Telepathology: is there added value in LMICs?

Everolimus extends PFS for HR positive, HER2 negative breast cancer

Dr Noah Kornblum - Montefiore Medical Center, New York, USA
Everolimus extends PFS for HR positive, HER2 negative breast cancer ( Dr Noah Kornblum - Montefiore Medical Center, New York, USA )
9 Dec 2016

TEAM IIb trial results: Adjuvant ibandronate in early breast cancer

Prof Sabine Linn - Netherlands Cancer Institute, Amsterdam, The Netherlands
TEAM IIb trial results: Adjuvant ibandronate in early breast cancer ( Prof Sabine Linn - Netherlands Cancer Institute, Amsterdam, The Netherlands )
9 Dec 2016

Neoadjuvant abemaciclib for HR positive, HER negative breast cancer

Dr Sara Hurvitz - Ronald Reagan UCLA Medical Center, Los Angeles, USA
Neoadjuvant abemaciclib for HR positive, HER negative breast cancer ( Dr Sara Hurvitz - Ronald Reagan UCLA Medical Center, Los Angeles, USA )
8 Dec 2016

TCHP with/out oestrogen for HR/HER positive breast cancer

Dr Mothaffar Rimawi - Baylor College of Medicine, Houston, USA
TCHP with/out oestrogen for HR/HER positive breast cancer ( Dr Mothaffar Rimawi - Baylor College of Medicine, Houston, USA )
8 Dec 2016

Efficacy of veliparib with carboplatin and paclitaxel for BRCA1/2 mutations in metastatic breast cancer

Dr Heather Han - H. Lee Moffitt Cancer Center, Tampa, USA
Efficacy of veliparib with carboplatin and paclitaxel for BRCA1/2 mutations in metastatic breast cancer ( Dr Heather Han - H. Lee Moffitt Cancer Center, Tampa, USA )
7 Dec 2016

Extended adjuvant endrocine therapy with letrozole after aromatase inhibition

Dr Terry Mamounas - UF Health Center, Orlando, USA
Extended adjuvant endrocine therapy with letrozole after aromatase inhibition ( Dr Terry Mamounas - UF Health Center, Orlando, USA )
7 Dec 2016

Whole exome and transcriptome sequencing of resistant ER positive metastatic breast cancer

Dr Ofir Cohen - Broad Institute of MIT and Harvard, Cambridge, USA
Whole exome and transcriptome sequencing of resistant ER positive metastatic breast cancer ( Dr Ofir Cohen - Broad Institute of MIT and Harvard, Cambridge, USA )
7 Dec 2016

PrECOG: Added everolimus extends PFS for HR positive, HER2 negative breast cancer

Dr Noah Kornblum - Montefiore Medical Center, New York, USA
PrECOG: Added everolimus extends PFS for HR positive, HER2 negative breast cancer ( Dr Noah Kornblum - Montefiore Medical Center, New York, USA )
7 Dec 2016

ASH 2016: Multiple myeloma highlights

Prof Marivi Mateos, Prof Philippe Moreau, Prof Saad Usmani, Prof Heinz Ludwig
ASH 2016: Multiple myeloma highlights ( Prof Marivi Mateos, Prof Philippe Moreau, Prof Saad Usmani, Prof Heinz Ludwig )
6 Dec 2016

Interim results from the ZUMA-1 trial of novel CAR-T cells against non-Hodgkin lymphoma

Dr Sattva Neelapu - MD Anderson Cancer Center, Houston, USA
Interim results from the ZUMA-1 trial of novel CAR-T cells against non-Hodgkin lymphoma ( Dr Sattva Neelapu - MD Anderson Cancer Center, Houston, USA )
6 Dec 2016

Pacritinib versus best available therapy for low platelet Myelofibrosis

Dr John Mascarenhas - Mount Sinai School of Medicine New York, USA
Pacritinib versus best available therapy for low platelet Myelofibrosis ( Dr John Mascarenhas - Mount Sinai School of Medicine New York, USA )
6 Dec 2016

Dose escalation of CPI-613 with bendamustine for relapsed T Cell NHL

Dr Zanetta Lamar - Wake Forest Baptist Medical Center, Winston-Salem, USA
Dose escalation of CPI-613 with bendamustine for relapsed T Cell NHL ( Dr Zanetta Lamar - Wake Forest Baptist Medical Center, Winston-Salem, USA )
6 Dec 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation